FLXN - Flexion Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $32.34. This is a potential upside of $7.05 (27.88%) from yesterday's end of day stock price of $25.29.

Flexion Therapeutics's activity chart (see below) currently has 71 price targets and 59 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.43% with an average time for these price targets to be met of 848.85 days.

Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL on 19-Nov-2021. First documented stock forecast 10-Sep-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$10

3 years 9 months 5 days ago
(19-Nov-2021)

2/3 (66.67%)

$0.7 (7.53%)

1400

Buy

$10

$0.88 (9.65%)

$25

3 years 10 months 4 days ago
(20-Oct-2021)

0/3 (0%)

$10.81 (62.86%)

Hold

$12

$-13.29 (-52.55%)

$20

3 years 10 months 11 days ago
(13-Oct-2021)

3/10 (30%)

$2.62 (27.93%)

1558

Buy

$10

$0.88 (9.65%)

$14

3 years 10 months 11 days ago
(13-Oct-2021)

0/7 (0%)

$5.58 (57.81%)

Hold

$16

3 years 10 months 12 days ago
(12-Oct-2021)

2/4 (50%)

$6.62 (70.58%)

1900

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FLXN (Flexion Therapeutics) average time for price targets to be met?

On average it took 848.85 days on average for the stock forecasts to be realized with a an average price target met ratio 31.43

Which analyst has the current highest performing score on FLXN (Flexion Therapeutics) with a proven track record?

SERGE BELANGER

Which analyst has the most public recommendations on FLXN (Flexion Therapeutics)?

Serge Belanger works at NEEDHAM and has 4 price targets and 7 ratings on FLXN

Which analyst is the currently most bullish on FLXN (Flexion Therapeutics)?

Martin Auster with highest potential upside - $4.88

Which analyst is the currently most reserved on FLXN (Flexion Therapeutics)?

Gary Nachman with lowest potential downside - -$13.29

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?